Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Operating expenses:
Research and development	$ 4,225	$ 1,947
Sales and marketing	22	866
General and administrative	5,295	4,809
Total operating expenses	9,542	7,622
Loss from operations	(9,542)	(7,622)
Other income (expense):
Interest income	3	29
Interest expense	(6,178)	(1,151)
Foreign exchange gain	11	13
Income (expense) from diverted funds and insurance claim, net		224
Re-measurement of derivative liabilities	(1,683)	482
Gain on write-off of accounts payable	101
Other expense, net	(7,746)	(403)
Loss before income tax expense	(17,288)	(8,025)
Income tax expense	45	13
Net loss	$ (17,333)	$ (8,038)
Basic and diluted net loss per common share (in Dollars per share)	$ (0.67)	$ (0.59)
Weighted-average number of common shares used in basic and diluted net loss per common share (in Shares)	25,886,615	13,699,585